Skip to main content
Imprivata logo
  • Request a demo
  • Support
United States
  • United States
  • DACH
  • French
  • United Kingdom

Main Nav (2025)

    • State of mobile in healthcare
      Shared mobile devices in healthcare research report
      Our comprehensive report examines the real-world impacts of shared-use mobile devices on healthcare organizations and clinical staff.
      Learn more
    • Left column
      • By Objective
        • Move to passwordless authentication
        • Access shared devices and kiosks
        • Deploy shared mobile devices
        • Control third-party access
        • Address cyber insurance requirements
        • Improve EHR workflows
        • Protect patient privacy
        • Achieve CJIS compliance
        • Face authentication and identity verification
    • Right column
      • By Industry
        • Healthcare
        • Manufacturing
        • State and Local Government
        • Financial Services
        • Gaming
        • Transportation and Logistics
    • Roadmaps
      Product roadmaps
      Explore recently released features and future items.
      Learn more
    • Left column
      • Core capabilities
        • Single Sign-On
        • Multifactor Authentication
        • Mobile Access
        • User Behavior and Access Analytics
        • Privileged Access Management
        • Third Party Access Management
        • Remote Support
        • Identity Threat Detection and Response
    • Right column
      • Healthcare capabilities
        • Patient Privacy Monitoring
        • Drug Diversion Monitoring
        • Medical Device Access Management
        • Biometric Patient Authentication
        • Electronic Prescribing for Controlled Substances (EPCS)
    • About us
      We deliver simple and secure access management solutions for healthcare and other mission-critical industries to ensure every second of crucial work is both frictionless and secure.
      See details
      Contact us
    • Left column
      • Who we are
        • Imprivata culture
        • Corporate responsibility
        • Trust and security
        • Leadership
    • Right column
      • What’s new
        • Newsroom
        • Podcast
        • Awards and recognition
        • Careers
    • Knowledge hub
      The Imprivata Knowledge Hub is a repository of important terms, topics, and solutions related to identity and access management. Browse content by product or industry to learn about securing assets, compliance across sectors, technology glossaries, and advancements in protecting identities and systems.
      Check it out
    • Left column
      • Events
        • Live events
        • On-demand webinars
      • Partners
        • Integration partners
        • Resellers
    • Right column
      • Resources
        • Blog
        • Analyst reports
        • Case studies
        • Whitepapers
        • Datasheets
        • Videos
        • Infographics
        • All resources
    • Connect logo
      Imprivata Connect
      The Imprivata Connect Conference series brings together visionary minds from the Imprivata community for a day of networking and collaboration in the spirit of shaping the future of simple and secure access management for every digital identity.
      Learn more
    • Left column
      • Customer experience
        • Customer success
        • Support services
        • Managed services
        • Clinical services
    • Right column
      • Resources
        • Education center
        • Community portal
        • Product documentation
The search found 3759 results.
Video
Fast, convenient, push token notification order signing process for electronic prescribing of controlled substances (EPCS)
Datasheet
Fast, easy authentication for mobile EPCS in Epic Haiku and Canto
Webinar
Fast, secure access to VMware Horizon Cloud on Microsoft Azure
Datasheet
Fast, secure access to Welch Allyn Connex vital signs devices
Blog
FDA Approves Drug 10 Times Stronger than Fentanyl: What It Means for Drug Diversion Prevention
With the newest FDA approved drug being 10x stronger than Fentanyl, this could cause cases of drug diversion. Find out how to prevent prescription pilfering in this post.
Blog
FDA Cybersecurity Guidance: Added Security…But at What Cost?
Last week, the FDA issued guidance to improve cybersecurity efforts in healthcare, warning that computer viruses could “affect how a medical device operates” and potentially expose personal health information. The memo provides general recommendations to both medical device manufacturers and healthcare facilities about how to defend against malware and other threats.
News
Federal Law Would Fight Opioid Epidemic with E-prescribing.
News
FEDTECH MAGAZINE - Sign of the Times
Blog
Feeling the Pain of Meaningful Use Stage 2? Try Vicodin
Introducing Electronic Prescribing of Controlled Substances (EPCS) is a great way to meet the challenging Stage 2 requirements for Meaningful Use.
News
Feeling the Pain of Meaningful Use? Try Vicodin

Pagination

  • First page 
  • Previous page 
  • …
  • Page 99
  • Page 100
  • Page 101
  • Page 102
  • Page 103
  • …
  • Next page 
  • Last page 
United States
  • United States
  • DACH
  • French
  • United Kingdom
  • Company
    • Who we are
    • Leadership
    • History
    • Integrations
    • Resellers
    • Trust and security
    • Careers
    • Newsroom
  • Product
    • Enterprise Access Management
    • Mobile Access Management
    • Mobile Device Access
    • Medical Device Access Management
    • Patient Access
    • Access Compliance
    • Privileged Access Management
    • Vendor Privileged Access Management
    • Customer Privileged Access Management
  • How to buy
    • Request demo
    • Contact us
  • Resources
    • Blog
    • Case studies
    • Analyst reports
    • Whitepapers
    • Datasheets
    • Videos
    • On-demand webinars
    • Infographics
    • Events and webinars
    • Knowledge hub
  • Worldwide headquarters

    20 CityPoint, 6th floor

    480 Totten Pond Rd

    Waltham, MA 02451

    Phone: +1 781 674 2700

    Toll-free: +1 877 663 7446

    International

    London: +44 (0)208 744 6500

    Germany: +49 (0)2173993850

    Australia: +61 3 8844 5533

    France: contactfrance@imprivata.com

    • 
    • 
    • 
    • 
  • Imprivata Logo
  • Post Footer Menu
    • Sitemap
    • Legal
    • Trust and Security
    • Privacy Policy
    • Cookie Policy
  • © 2025 Imprivata, Inc. All rights reserved.